HomeCompareCTHRQ vs SPHD

CTHRQ vs SPHD: Dividend Comparison 2026

CTHRQ yields 39215.69% · SPHD yields 4.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTHRQ wins by $4.252735580217355e+22M in total portfolio value
10 years
CTHRQ
CTHRQ
● Live price
39215.69%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.252735580217355e+22M
Annual income
$42,315,093,309,418,040,000,000,000,000.00
Full CTHRQ calculator →
SPHD
SPHD
● Live price
4.30%
Share price
$49.61
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$567.37
Full SPHD calculator →

Portfolio growth — CTHRQ vs SPHD

📍 CTHRQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTHRQSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTHRQ + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTHRQ pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTHRQ
Annual income on $10K today (after 15% tax)
$3,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$35,967,829,313,005,333,000,000,000,000.00/yr
SPHD
Annual income on $10K today (after 15% tax)
$365.92/yr
After 10yr DRIP, annual income (after tax)
$482.26/yr
At 15% tax rate, CTHRQ beats the other by $35,967,829,313,005,333,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTHRQ + SPHD for your $10,000?

CTHRQ: 50%SPHD: 50%
100% SPHD50/50100% CTHRQ
Portfolio after 10yr
$2.1263677901086776e+22M
Annual income
$21,157,546,654,709,020,000,000,000,000.00/yr
Blended yield
99.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CTHRQ right now

CTHRQ
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-3.9
Piotroski
2/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTHRQ buys
0
SPHD buys
0
No recent congressional trades found for CTHRQ or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTHRQSPHD
Forward yield39215.69%4.30%
Annual dividend / share$2.00$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.252735580217355e+22M$26.5K
Annual income after 10y$42,315,093,309,418,040,000,000,000,000.00$567.37
Total dividends collected$4.251340866571809e+22M$5.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CTHRQ vs SPHD ($10,000, DRIP)

YearCTHRQ PortfolioCTHRQ Income/yrSPHD PortfolioSPHD Income/yrGap
1← crossover$3,932,269$3,921,568.63$11,130$430.50+$3.92MCTHRQ
2$1,445,390,825$1,441,183,297.58$12,357$447.82+$1445.38MCTHRQ
3$496,629,048,205$495,082,480,022.34$13,687$464.65+$496629.03MCTHRQ
4$159,510,701,964,776$158,979,308,883,196.16$15,126$480.98+$159510701.95MCTHRQ
5$47,892,225,784,148,210$47,721,549,333,045,900.00$16,682$496.78+$47892225784.13MCTHRQ
6$13,442,027,069,357,296,000$13,390,782,387,768,257,000.00$18,362$512.03+$13442027069357.28MCTHRQ
7$3,526,928,149,355,307,700,000$3,512,545,180,391,095,400,000.00$20,174$526.72+$3526928149355307.50MCTHRQ
8$865,104,634,553,737,800,000,000$861,330,821,433,927,700,000,000.00$22,127$540.84+$865104634553737856.00MCTHRQ
9$198,376,161,453,751,100,000,000,000$197,450,499,494,778,630,000,000,000.00$24,230$554.39+$198376161453751107584.00MCTHRQ
10$42,527,355,802,173,560,000,000,000,000$42,315,093,309,418,040,000,000,000,000.00$26,493$567.37+$4.252735580217355e+22MCTHRQ

CTHRQ vs SPHD: Complete Analysis 2026

CTHRQStock

Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. It operates through two segments: Online Channels and Traditional. The company manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. It also markets and distributes lab grown diamonds and finished jewelry with lab grown diamonds under the Caydia brand. It sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com and moissaniteoutlet.com, third-party online marketplaces, drop-ship, and other e-commerce outlets, as well as through Charles & Colvard Signature Showroom and charlesandcolvarddirect.com for wholesale and retail customers. Charles & Colvard, Ltd. was incorporated in 1995 and is headquartered in Morrisville, North Carolina. On March 2, 2026, Charles & Colvard, Ltd. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Eastern District of North Carolina.

Full CTHRQ Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this CTHRQ vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTHRQ vs SCHDCTHRQ vs JEPICTHRQ vs OCTHRQ vs KOCTHRQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.